Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Merck Announces FDA Acceptance of Supplemental New Drug Application for ISENTRESS® (raltegravir) in Adult Patients ... (Business Wire via Yahoo! Finance) |
 |
 |
|
WHITEHOUSE STATION, N.J.----Merck & Co., Inc. today announced that the U.S. Food and Drug Administration has accepted the supplemental New Drug Application filing for ISENTRESS® Tablets for standard review. |
